Common Antimicrobials Used for Chronic Oral Antimicrobial Suppression
(B-III Unless Otherwise Stated in Text)\textsuperscript{a,b}

\begin{tabular}{ccc}
\toprule
Microorganism & Preferred Treatment & Alternative Treatment\\
\midrule
Staphylococci, oxacillin-susceptible & Cephalexin 500 mg PO tid or qid\newline or\newline Cefadroxil 500 mg PO bid & Dicloxacillin 500 mg PO tid or qid\newline Clindamycin 300 mg PO qid\newline Amoxicillin-clavulanate 500 mg PO tid\\
Staphylococci, oxacillin-resistant & Cotrimoxazole 1 DS tab PO bid\newline Minocycline or doxycycline 100 mg PO bid & \\
β-hemolytic streptococci & Penicillin V 500 mg PO bid to qid\newline or\newline Amoxicillin 500 mg PO tid  & Cephalexin 500 mg PO tid or qid\\
\emph{Enterococcus} spp, penicillin-susceptible & Penicillin V 500 mg PO bid to qid\newline or\newline Amoxicillin 500 mg PO tid &\\
\emph{Pseudomonas aeruginosa} & Ciprofloxacin 250--500 mg PO bid & \\
Enterobacteriaceae & Cotrimoxazole 1 DS tab PO bid & β-lactam oral therapy based on in vitro susceptibilities \\
\emph{Propionibacterium} spp & Penicillin V 500 mg PO bid to qid\newline or\newline Amoxicillin 500 mg PO tid & Cephalexin 500 mg PO tid or qid\newline \newline Minocycline or doxycycline 100 mg PO bid \\
\bottomrule
\end{tabular}

Abbreviations: bid, twice daily; DS, double strength; PO, per oral; qid,
4 times daily; tid, 3 times daily.

\textsuperscript{a} Antimicrobial dosage needs to be adjusted based on
patients' renal and hepatic function. Antimicrobials should be chosen
based on in vitro susceptibility as well as patient drug allergies,
intolerances, and potential drug interactions or contraindications to a
specific antimicrobial.

\textsuperscript{b} Clinical and laboratory monitoring for efficacy and
safety should occur based on the clinical judgment of the clinician
caring for the patient. The possibility of prolonged QTc interval and
tendinopathy should be discussed and monitored when using
fluoroquinolones. The possibility of \emph{Clostridium difficile}
colitis should also be discussed when using any antimicrobial.
